Provided by Tiger Trade Technology Pte. Ltd.

Ionis Pharmaceuticals

59.88
-0.4800-0.80%
Pre-market: 59.58-0.3000-0.50%05:17 EDT
Volume:1.87M
Turnover:112.59M
Market Cap:9.95B
PE:-17.21
High:60.99
Open:60.37
Low:59.78
Close:60.36
52wk High:86.74
52wk Low:49.13
Shares:166.18M
Float Shares:161.92M
Volume Ratio:0.93
T/O Rate:1.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4800
EPS(LYR):-2.3812
ROE:-105.50%
ROA:-12.42%
PB:22.63
PE(LYR):-25.15

Loading ...

Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Feb 07, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Feb 07, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Feb 07, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Feb 07, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Feb 07, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Feb 07, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Feb 07, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Jan 19, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Jan 19, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Jan 19, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Jan 19, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Jan 19, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Jan 19, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Jan 09, 2023

Major Issues Report

8-K - Current report
Nov 14, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2022

Major Issues Report

8-K - Current report